Growth Metrics

Arcus Biosciences (RCUS) Times Interest Earned (2023 - 2026)

Arcus Biosciences' quarterly Times Interest Earned came in at -$44.67 in Q1 2026, up 63.39% year-on-year from -$27.34 in Q1 2025, and up 21.64% quarter-over-quarter from -$57.0 in Q4 2025.

Arcus Biosciences has reported Times Interest Earned for 4 years, with the latest figure at -$44.67 in Q1 2026.

  • For the quarter ending Q1 2026, Times Interest Earned rose 63.39% year-over-year to -$44.67; the trailing twelve-month figure through Mar 2026 stood at -$39.8 (up 63.49% YoY), and the FY2025 full-year result was -$48.25, up 41.52% from the prior year.
  • Times Interest Earned for Q1 2026 stood at -$44.67, up from -$57.0 in the prior quarter.
  • The five-year high for Times Interest Earned was -$4.0 in Q2 2025, with the low at -$122.0 in Q1 2025.
  • Average Times Interest Earned over 4 years is -$58.61, with a median of -$51.5 recorded in 2024.
  • Year-over-year, Times Interest Earned tumbled 662.5% in 2025 and surged 63.39% in 2026.
  • Tracing RCUS's Times Interest Earned over 4 years: stood at -$80.0 in 2023, then surged by 35.62% to -$51.5 in 2024, then fell by 10.68% to -$57.0 in 2025, then increased by 21.64% to -$44.67 in 2026.
  • The last three Times Interest Earned figures came in at -$44.67 (Q1 2026), -$57.0 (Q4 2025), and -$47.33 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -129.79
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -258.33
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - 11.50
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.88
10 Arcus Biosciences 3.18 Bn 2.36 Bn - -44.67

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -44.67
Dec 31, 2025 -57.00
Sep 30, 2025 -47.33
Jun 30, 2025 -4.00
Mar 31, 2025 -122.00
Dec 31, 2024 -51.50
Sep 30, 2024 -105.00
Mar 31, 2024 -16.00
Sep 30, 2023 -80.00